Archives of Clinical and Biomedical ResearchNeurosciencePeer-reviewed journal article
Pharmacological characterization of FC-12738: A novel retro-inverso pentapeptide for treating neuroinflammation
Abstract
FC-12738, a retro-inverso pentapeptide developed by Neurodegenerative Disease Research, Inc., is currently under investigation for treating neuroinflammation associated with amyotrophic lateral sclerosis (ALS). This study aimed to evaluate the pharmacokinetic properties of FC-12738, including absorption, distribution, metabolism, excretion, and drug-drug interactions. Pharmacokinetics were assessed in Sprague-Dawley rats and beagle dogs following intravenous and subcutaneous administration. Our findings suggest that FC-12738 demonstrates many favorable pharmacokinetic properties, although further optimization may be required to improve CNS penetrance.
- organism: rat
- organism: mouse
- research focus: drug response / drug discovery
- approach: experimental assay
- Citations
- 0
- FWCI
- 0.00
- Field percentile
- 28th percentile
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Dizocilpine derivatives with neuroprotective effect lacking the psychomimetic side effects
Jan Konecny, Anna Misiachna, … Martin Hořák·bioRxiv·Jun 17, 2024
- Stealth liposomes encapsulating a potent ACAT1/SOAT1 inhibitor F12511: pharmacokinetic, biodistribution and toxicity studies in wild-type mice, and efficacy studies in triple transgenic Alzheimer Disease mice.
Adrianna L. De La Torre, Thao Nguyen Thanh Huynh, … Ta‐Yuan Chang·bioRxiv·May 2, 2023
- Molecular Dynamics studies of Long Neurotoxins against nAChR provide key insights towards design of therapeutic peptides for Dyskinesia
Shivam Pandit, Gargi Saha, … H.G. Nagendra·bioRxiv·May 22, 2023
- Druggability of Phospholipase C-β Isoforms with Small Peptides Patterned after the Autoinhibitory XY Linker
Jorge de Andrés-López, David Cabañero, … Antonio Vicente Ferrer-Montiel·bioRxiv·Jul 22, 2025
- Large- and Small-Animal Studies of Safety, Pharmacokinetics (PK), and Biodistribution of Inflammasome-Targeting Nanoligomer in the Brain and Other Target Organs
- Neuroprotection by chronic administration of Fluoroethylnormemantine (FENM) in mouse models of Alzheimer's disease
Allison Carles, Aline Freyssin, … Tangui Maurice·Alzheimer s Research & TherapyPeer-reviewed·Jan 6, 2025